| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | FAT1 NAALADL1 GUCA1C HMCN2 PCDHGB7 CADPS NINL DYSF PCDHB1 ITIH1 NCS1 C2CD5 MICU1 | 5.37e-05 | 749 | 95 | 13 | GO:0005509 |
| GeneOntologyMolecularFunction | myosin V binding | 1.12e-04 | 20 | 95 | 3 | GO:0031489 | |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 1.34e-04 | 4 | 95 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 1.34e-04 | 4 | 95 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 1.34e-04 | 4 | 95 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 1.96e-04 | 24 | 95 | 3 | GO:0030742 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 3.32e-04 | 6 | 95 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | calcium sensitive guanylate cyclase activator activity | 3.32e-04 | 6 | 95 | 2 | GO:0008048 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 4.63e-04 | 7 | 95 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 6.11e-04 | 35 | 95 | 3 | GO:0008157 | |
| GeneOntologyMolecularFunction | guanylate cyclase activator activity | 6.16e-04 | 8 | 95 | 2 | GO:0030250 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 6.16e-04 | 8 | 95 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | guanylate cyclase regulator activity | 7.89e-04 | 9 | 95 | 2 | GO:0030249 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 9.83e-04 | 10 | 95 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 9.83e-04 | 10 | 95 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 1.20e-03 | 11 | 95 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.69e-03 | 13 | 95 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 1.69e-03 | 13 | 95 | 2 | GO:0010853 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 1.96e-03 | 14 | 95 | 2 | GO:1901474 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.51e-03 | 119 | 95 | 4 | GO:0015294 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 7.79e-06 | 9 | 95 | 3 | GO:0160063 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 7.49e-06 | 9 | 95 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.19e-05 | 14 | 95 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | presynapse | EPHB2 EFNB1 ADAM23 CADPS GLRA3 RAB3D DYSF RAB3B DENND1A RAB3C NCS1 HTT PPP1CA PPP1CC | 4.57e-05 | 886 | 95 | 14 | GO:0098793 |
| GeneOntologyCellularComponent | protein phosphatase type 1 complex | 8.36e-05 | 19 | 95 | 3 | GO:0000164 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 4.23e-04 | 7 | 95 | 2 | GO:0072357 | |
| Domain | DUF2012 | 5.08e-07 | 4 | 95 | 3 | PF09430 | |
| Domain | DUF2012 | 5.08e-07 | 4 | 95 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 7.01e-06 | 8 | 95 | 3 | IPR013784 | |
| Domain | CarboxyPept_regulatory_dom | 3.51e-05 | 13 | 95 | 3 | IPR014766 | |
| Domain | - | 3.51e-05 | 13 | 95 | 3 | 2.60.40.1120 | |
| Domain | CNT_N_dom | 7.65e-05 | 3 | 95 | 2 | IPR002668 | |
| Domain | C_nuclsd_transpt | 7.65e-05 | 3 | 95 | 2 | IPR008276 | |
| Domain | CNT_C_dom | 7.65e-05 | 3 | 95 | 2 | IPR011657 | |
| Domain | C_nuclsd_transpt_met_bac | 7.65e-05 | 3 | 95 | 2 | IPR018270 | |
| Domain | Gate_dom | 7.65e-05 | 3 | 95 | 2 | IPR011642 | |
| Domain | Nucleos_tra2_N | 7.65e-05 | 3 | 95 | 2 | PF01773 | |
| Domain | STPPase_N | 7.65e-05 | 3 | 95 | 2 | IPR031675 | |
| Domain | STPPase_N | 7.65e-05 | 3 | 95 | 2 | PF16891 | |
| Domain | Nucleos_tra2_C | 7.65e-05 | 3 | 95 | 2 | PF07662 | |
| Domain | Gate | 7.65e-05 | 3 | 95 | 2 | PF07670 | |
| Domain | CarboxyPept-like_regulatory | 8.23e-05 | 17 | 95 | 3 | IPR008969 | |
| Domain | MARK/par1 | 1.53e-04 | 4 | 95 | 2 | IPR033624 | |
| Domain | KA1_dom | 2.53e-04 | 5 | 95 | 2 | IPR001772 | |
| Domain | KA1 | 2.53e-04 | 5 | 95 | 2 | PF02149 | |
| Domain | KA1 | 2.53e-04 | 5 | 95 | 2 | PS50032 | |
| Domain | - | 2.53e-04 | 5 | 95 | 2 | 3.30.310.80 | |
| Domain | CH | 3.35e-04 | 65 | 95 | 4 | SM00033 | |
| Domain | FAD-bd | 3.79e-04 | 6 | 95 | 2 | IPR002938 | |
| Domain | FAD_binding_3 | 3.79e-04 | 6 | 95 | 2 | PF01494 | |
| Domain | CH | 4.45e-04 | 70 | 95 | 4 | PF00307 | |
| Domain | UBA | 4.69e-04 | 30 | 95 | 3 | SM00165 | |
| Domain | - | 4.70e-04 | 71 | 95 | 4 | 1.10.418.10 | |
| Domain | CH | 5.23e-04 | 73 | 95 | 4 | PS50021 | |
| Domain | KA1/Ssp2_C | 5.29e-04 | 7 | 95 | 2 | IPR028375 | |
| Domain | CH-domain | 5.79e-04 | 75 | 95 | 4 | IPR001715 | |
| Domain | UBA | 8.06e-04 | 36 | 95 | 3 | PF00627 | |
| Domain | UBA | 1.45e-03 | 44 | 95 | 3 | IPR015940 | |
| Domain | UBA | 1.76e-03 | 47 | 95 | 3 | PS50030 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 1.93e-03 | 13 | 95 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 1.93e-03 | 13 | 95 | 2 | PS00125 | |
| Domain | PP2Ac | 1.93e-03 | 13 | 95 | 2 | SM00156 | |
| Domain | Recoverin | 1.93e-03 | 13 | 95 | 2 | IPR028846 | |
| Domain | Pept_M10A_stromelysin-type | 3.71e-03 | 18 | 95 | 2 | IPR016293 | |
| Domain | P-loop_NTPase | ARHGAP5 PALS1 TRANK1 KIF27 RRAGD DHX40 DDX60 RAB3D RAB3B HYDIN RAB3C | 3.82e-03 | 848 | 95 | 11 | IPR027417 |
| Domain | RRM_1 | 4.21e-03 | 208 | 95 | 5 | PF00076 | |
| Domain | PG_binding_1 | 4.58e-03 | 20 | 95 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 4.58e-03 | 20 | 95 | 2 | IPR002477 | |
| Domain | - | ARHGAP5 PALS1 TRANK1 RRAGD DHX40 DDX60 RAB3D RAB3B HYDIN RAB3C | 4.62e-03 | 746 | 95 | 10 | 3.40.50.300 |
| Domain | RRM | 5.03e-03 | 217 | 95 | 5 | SM00360 | |
| Domain | Ras | 5.14e-03 | 136 | 95 | 4 | PF00071 | |
| Domain | LIM | 5.24e-03 | 69 | 95 | 3 | PF00412 | |
| Domain | - | 5.46e-03 | 70 | 95 | 3 | 2.10.110.10 | |
| Domain | Znf_LIM | 5.68e-03 | 71 | 95 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 5.68e-03 | 71 | 95 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 5.68e-03 | 71 | 95 | 3 | PS50023 | |
| Domain | LIM | 5.68e-03 | 71 | 95 | 3 | SM00132 | |
| Domain | Hemopexin-like_dom | 6.04e-03 | 23 | 95 | 2 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 6.04e-03 | 23 | 95 | 2 | IPR018487 | |
| Domain | M10A_MMP | 6.04e-03 | 23 | 95 | 2 | IPR033739 | |
| Domain | Hemopexin | 6.04e-03 | 23 | 95 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 6.04e-03 | 23 | 95 | 2 | PS00024 | |
| Domain | - | 6.04e-03 | 23 | 95 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 6.04e-03 | 23 | 95 | 2 | PS51642 | |
| Domain | HX | 6.04e-03 | 23 | 95 | 2 | SM00120 | |
| Domain | Pept_M10A | 6.04e-03 | 23 | 95 | 2 | IPR021190 | |
| Domain | RRM_dom | 6.07e-03 | 227 | 95 | 5 | IPR000504 | |
| Pubmed | PALS1 EDC3 AKAP9 LMO7 MARK1 MARK3 NINL SH3GLB2 FRYL ECH1 DENND1A C2CD5 PPP1CA | 3.28e-10 | 446 | 96 | 13 | 24255178 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 36011023 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 32742255 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.04e-08 | 3 | 96 | 3 | 25576386 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 12167638 | ||
| Pubmed | Rab3 proteins involved in vesicle biogenesis and priming in embryonic mouse chromaffin cells. | 8.14e-08 | 4 | 96 | 3 | 20716109 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 15269275 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 8.14e-08 | 4 | 96 | 3 | 31833031 | |
| Pubmed | Rab3 superprimes synaptic vesicles for release: implications for short-term synaptic plasticity. | 8.14e-08 | 4 | 96 | 3 | 16436611 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 9267806 | ||
| Pubmed | Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption. | 2.03e-07 | 5 | 96 | 3 | 21262767 | |
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 11598194 | ||
| Pubmed | Noc2 is essential in normal regulation of exocytosis in endocrine and exocrine cells. | 2.03e-07 | 5 | 96 | 3 | 15159548 | |
| Pubmed | The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. | 2.03e-07 | 5 | 96 | 3 | 17511879 | |
| Pubmed | The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators. | 4.05e-07 | 6 | 96 | 3 | 31679900 | |
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 12192047 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 6.21e-07 | 258 | 96 | 8 | 37794589 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP5 EDC3 NOMO2 OSBPL3 DHX40 NINL MICAL3 ECH1 PC RAB3B RBM39 HNRNPH3 FHIP2B | 6.57e-07 | 853 | 96 | 13 | 28718761 |
| Pubmed | Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. | 7.08e-07 | 7 | 96 | 3 | 35871249 | |
| Pubmed | Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function. | 7.08e-07 | 7 | 96 | 3 | 33542309 | |
| Pubmed | ARHGAP5 EXOSC10 SPATS2L TXNDC5 AKAP9 IPO7 RRAGD LMO7 MARK3 OSBPL3 RPS19BP1 ECH1 PC DENND1A LARP7 PPP1CC | 1.06e-06 | 1371 | 96 | 16 | 36244648 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.13e-06 | 8 | 96 | 3 | 15257293 | |
| Pubmed | HNRNPDL ARHGAP5 EXOSC10 ERCC4 EDC3 RRAGD MARK1 PIK3CD SLC20A1 OSBPL3 RAB3D FRYL C2CD5 FHIP2B | 1.67e-06 | 1084 | 96 | 14 | 11544199 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.69e-06 | 9 | 96 | 3 | 36261522 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HNRNPDL PALS1 EXOSC10 SPATS2L IPO7 LMO7 MARK3 DDX60 PNO1 SPEN RBM39 HNRNPH3 PPP1CA PPP1CC MICU1 | 1.82e-06 | 1257 | 96 | 15 | 36526897 |
| Pubmed | EXOSC10 EFNB1 TXNDC5 AKAP9 IPO7 NOMO2 MARK3 SLC20A1 SYNE2 DNAJB7 ECH1 LARP7 C2CD5 NOMO1 PPP1CC MICU1 | 3.01e-06 | 1487 | 96 | 16 | 33957083 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 3.31e-06 | 11 | 96 | 3 | 32820719 | |
| Pubmed | 5.38e-06 | 244 | 96 | 7 | 29884807 | ||
| Pubmed | VPS13D NOMO2 TTC27 RO60 PC NOMO3 HNRNPH3 PPP1CA NOMO1 PPP1CC | 7.05e-06 | 606 | 96 | 10 | 36538041 | |
| Pubmed | Identification and characterization of multiple novel Rab-myosin Va interactions. | 7.26e-06 | 14 | 96 | 3 | 24006491 | |
| Pubmed | Cell segregation and border sharpening by Eph receptor-ephrin-mediated heterotypic repulsion. | 7.54e-06 | 2 | 96 | 2 | 28747399 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25789755 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23881165 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21832177 | ||
| Pubmed | In silico discovery and experimental validation of new protein-protein interactions. | 7.54e-06 | 2 | 96 | 2 | 21280221 | |
| Pubmed | EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. | 7.54e-06 | 2 | 96 | 2 | 12973358 | |
| Pubmed | Trans-synaptic Eph receptor-ephrin signaling in hippocampal mossy fiber LTP. | 7.54e-06 | 2 | 96 | 2 | 12052960 | |
| Pubmed | Elevated Plasma Levels of MT4-MMP and MT6-MMP; A New Observation in Patients with Thyroid Nodules. | 7.54e-06 | 2 | 96 | 2 | 38310435 | |
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 7.54e-06 | 2 | 96 | 2 | 23176181 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 10455109 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23874863 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25643922 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9882500 | ||
| Pubmed | Transcription factors involved in the expression of SLC28 genes in human liver parenchymal cells. | 7.54e-06 | 2 | 96 | 2 | 17187757 | |
| Pubmed | PALS1 TXNDC5 AKAP9 IPO7 LMO7 MARK3 MICAL2 PNO1 TTC27 RBM39 HNRNPH3 LARP7 PPP1CA PPP1CC | 8.32e-06 | 1247 | 96 | 14 | 27684187 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 9.72e-06 | 102 | 96 | 5 | 15778465 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 FAT1 PIK3CD NINL MICAL3 FRYL DYSF PC SPEN MMP17 MYRF DENND1A HTT | 1.10e-05 | 1105 | 96 | 13 | 35748872 |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 1.41e-05 | 283 | 96 | 7 | 18854154 | |
| Pubmed | HNRNPDL PALS1 EXOSC10 HMCN2 TXNDC5 IPO7 DHX40 FLAD1 RPS19BP1 PNO1 PC HNRNPH3 PPP1CA PPP1CC | 1.78e-05 | 1335 | 96 | 14 | 29229926 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 23408838 | ||
| Pubmed | Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. | 2.26e-05 | 3 | 96 | 2 | 12411296 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10087507 | ||
| Pubmed | Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network. | 2.26e-05 | 3 | 96 | 2 | 19074462 | |
| Pubmed | Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3. | 2.26e-05 | 3 | 96 | 2 | 17453413 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 21145462 | ||
| Pubmed | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. | 2.26e-05 | 3 | 96 | 2 | 25073485 | |
| Pubmed | Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock. | 2.26e-05 | 3 | 96 | 2 | 21712997 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17965019 | ||
| Pubmed | Nuk controls pathfinding of commissural axons in the mammalian central nervous system. | 2.26e-05 | 3 | 96 | 2 | 8689685 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 32337793 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 12138106 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 7857673 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 27810913 | ||
| Pubmed | Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. | 2.26e-05 | 3 | 96 | 2 | 11739654 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 28385889 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 32620380 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 11588169 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 25740824 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17668899 | ||
| Pubmed | Characterization of deoxyribonucleoside transport mediated by concentrative nucleoside transporters. | 2.26e-05 | 3 | 96 | 2 | 33910126 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 9882488 | ||
| Pubmed | EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. | 2.26e-05 | 3 | 96 | 2 | 23711177 | |
| Pubmed | Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. | 2.26e-05 | 3 | 96 | 2 | 12136247 | |
| Pubmed | 2.26e-05 | 421 | 96 | 8 | 36976175 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPDL EXOSC10 EFNB1 TXNDC5 IPO7 LMO7 SLC20A1 SYNE2 SPEN RBM39 HNRNPH3 PPP1CA | 2.56e-05 | 1024 | 96 | 12 | 24711643 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | VPS13D EDC3 AKAP9 LMO7 MARK3 OSBPL3 SYNE2 FRYL PC DENND1A PPP1CA | 2.61e-05 | 861 | 96 | 11 | 36931259 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PALS1 SPATS2L TXNDC5 NOMO2 OSBPL3 FLAD1 PNO1 SH3GLB2 MYRF C2CD5 | 3.06e-05 | 719 | 96 | 10 | 35337019 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HNRNPDL EDC3 SPATS2L LMO7 DDX60 DYSF SPEN RAB3B PPP1CA PPP1CC | 3.24e-05 | 724 | 96 | 10 | 36232890 |
| Pubmed | 3.95e-05 | 24 | 96 | 3 | 27754788 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB2 AKAP9 NOMO2 MARK1 MARK3 NOMO3 NCS1 C2CD5 PPP1CA NOMO1 PPP1CC | 4.32e-05 | 910 | 96 | 11 | 36736316 |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 23499489 | ||
| Pubmed | Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. | 4.51e-05 | 4 | 96 | 2 | 16131488 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 10194355 | ||
| Pubmed | Eph receptor interclass cooperation is required for the regulation of cell proliferation. | 4.51e-05 | 4 | 96 | 2 | 27565439 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 7651410 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 10880350 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 34551092 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 15226296 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 22492015 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 16943546 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 22768081 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 10807923 | ||
| Pubmed | Nuclear protein phosphatase-1 regulates HIV-1 transcription. | 4.51e-05 | 4 | 96 | 2 | 12788939 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 11431472 | ||
| Pubmed | Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. | 4.51e-05 | 4 | 96 | 2 | 24440334 | |
| Pubmed | Mechanisms Regulating the Association of Protein Phosphatase 1 with Spinophilin and Neurabin. | 4.51e-05 | 4 | 96 | 2 | 29786422 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 18635603 | ||
| Pubmed | The MICAL proteins and rab1: a possible link to the cytoskeleton? | 4.51e-05 | 4 | 96 | 2 | 15694364 | |
| Pubmed | Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. | 4.51e-05 | 4 | 96 | 2 | 23277204 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 12016225 | ||
| Interaction | RPH3A interactions | 1.12e-06 | 39 | 96 | 5 | int:RPH3A | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 1.15e-03 | 13 | 71 | 2 | 693 | |
| GeneFamily | RNA binding motif containing | 1.50e-03 | 213 | 71 | 5 | 725 | |
| GeneFamily | LIM domain containing | 1.61e-03 | 59 | 71 | 3 | 1218 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 2.13e-03 | 65 | 71 | 3 | 388 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 3.97e-03 | 24 | 71 | 2 | 891 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 HNRNPDL FAT1 SLC11A2 AKAP9 IPO7 MARK3 MICAL2 SYNE2 MICAL3 FRYL SPEN RBM39 HNRNPH3 C2CD5 | 5.06e-07 | 856 | 96 | 15 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 8.26e-06 | 466 | 96 | 10 | M13522 | |
| Coexpression | GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP | 8.53e-06 | 198 | 96 | 7 | M8423 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-06 | 185 | 96 | 6 | 9878392d79734ab5bb977d7f4f5e2e079b9a5353 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-06 | 197 | 96 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.09e-05 | 167 | 96 | 5 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 168 | 96 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.55e-05 | 172 | 96 | 5 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-05 | 172 | 96 | 5 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-05 | 176 | 96 | 5 | 6b04672f295d7680ba00714a72785314a619c893 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-05 | 177 | 96 | 5 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-05 | 177 | 96 | 5 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-05 | 177 | 96 | 5 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 180 | 96 | 5 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 4.53e-05 | 181 | 96 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-05 | 185 | 96 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 186 | 96 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 186 | 96 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 190 | 96 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 190 | 96 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.99e-05 | 192 | 96 | 5 | 5692bd57093852d442400383850f416c497dcc7d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.99e-05 | 192 | 96 | 5 | 0b506fb5bca54a50949932293c6f86d974a3acdd | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.99e-05 | 192 | 96 | 5 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.61e-05 | 196 | 96 | 5 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-05 | 197 | 96 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 197 | 96 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-05 | 199 | 96 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.10e-05 | 199 | 96 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 7.10e-05 | 199 | 96 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.27e-05 | 200 | 96 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 6.00e-05 | 4 | 94 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 2.22e-04 | 268 | 94 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | PITUITARY DWARFISM I | 3.56e-04 | 9 | 94 | 2 | C0342573 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.61e-04 | 105 | 94 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | bipolar disorder | 5.20e-04 | 577 | 94 | 8 | MONDO_0004985 | |
| Disease | phosphatidylcholine 40:7 measurement | 7.65e-04 | 13 | 94 | 2 | EFO_0021477 | |
| Disease | cutaneous melanoma, hair color | 1.03e-03 | 62 | 94 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 1.17e-03 | 16 | 94 | 2 | OBA_2045093 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.21e-03 | 145 | 94 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Manic Disorder | 1.53e-03 | 71 | 94 | 3 | C0024713 | |
| Disease | unipolar depression, bipolar disorder | 1.58e-03 | 156 | 94 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | hydrocephalus (implicated_via_orthology) | 1.66e-03 | 19 | 94 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | citrulline measurement | 1.84e-03 | 20 | 94 | 2 | EFO_0009777 | |
| Disease | bipolar disorder, schizophrenia, response to lithium ion | 1.84e-03 | 20 | 94 | 2 | GO_0010226, MONDO_0004985, MONDO_0005090 | |
| Disease | alcohol consumption measurement | ERCC4 AKAP9 CADPS MARK3 RPS19BP1 GLRA3 MICAL3 DENND1A LARP7 HTT PPP1CC | 1.99e-03 | 1242 | 94 | 11 | EFO_0007878 |
| Disease | Manic | 2.00e-03 | 78 | 94 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 2.08e-03 | 79 | 94 | 3 | C0005587 | |
| Disease | neuroimaging measurement | 2.16e-03 | 1069 | 94 | 10 | EFO_0004346 | |
| Disease | urate measurement | 2.23e-03 | 895 | 94 | 9 | EFO_0004531 | |
| Disease | Etat Marbre | 2.43e-03 | 23 | 94 | 2 | C0266487 | |
| Disease | Dwarfism | 2.87e-03 | 25 | 94 | 2 | C0013336 | |
| Disease | risk-taking behaviour | 3.07e-03 | 764 | 94 | 8 | EFO_0008579 | |
| Disease | Limb-girdle muscular dystrophy | 3.10e-03 | 26 | 94 | 2 | cv:C0686353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DQIGFQTFETVDVKF | 1496 | Q99996 | |
| ASFQIEAFGSKFILD | 151 | O75077 | |
| ATGSKDQTVFFFEVE | 591 | Q96MT7 | |
| AEGTVFTEEDFQKFQ | 116 | Q86WX3 | |
| AFGAVAEFSFVIDLQ | 386 | Q14498 | |
| DINFVFTGFSVNGKV | 121 | P69849 | |
| QLGFDFFEASAKENI | 156 | P20337 | |
| GFEFFETSAKDNINV | 166 | Q96E17 | |
| DLGFEFFEASAKENI | 156 | O95716 | |
| LFFANEKGANFHEVT | 131 | O75311 | |
| FGFVLFKDAASVDKV | 191 | O14979 | |
| FFGVADKAQHVFSLD | 281 | Q9Y5F8 | |
| QDFQFVVKATDGGFL | 526 | Q9Y5F3 | |
| AEFGQFFHATLIKAV | 491 | Q8NAB2 | |
| AFFNAVKEGDTVIFA | 591 | Q9ULU8 | |
| FFFTIVTGNDEKAFE | 3476 | Q14517 | |
| FDAIANIRGETFFFK | 321 | Q9NPA2 | |
| DINFVFTGFSVNGKV | 121 | Q5JPE7 | |
| GFDGNSIFNFKEVEV | 776 | Q14667 | |
| EEISGVAFIFNQKFF | 261 | Q7RTP6 | |
| TFVFNVFDENKDGRI | 66 | P62166 | |
| FISDFAVTADGNAFI | 96 | P19827 | |
| AGDFKTGVAFFEAAV | 41 | Q86YR5 | |
| FQKVGDFSAAFEILS | 2741 | Q8NDA2 | |
| DLVAAFDNGDQKVFF | 61 | Q7Z3E5 | |
| FFLFKLGAVENAAES | 1131 | Q8IY21 | |
| GKGLTFQEVENFFTF | 356 | Q9BPX6 | |
| KESFANAGFTSFDVV | 931 | P29323 | |
| TFDFVFGKNSTQDEV | 46 | Q86VH2 | |
| SKETGVRFAGADFVF | 621 | P51805 | |
| ADALAKAVAENFFVE | 361 | Q86V87 | |
| NEFAEVFLKAFAVGV | 286 | O95373 | |
| AFFQVKEVDVGLAAD | 191 | Q13011 | |
| QFGVFKDFDFLDVEL | 2421 | O94915 | |
| TNKDGFVDFLEFIAA | 66 | O95843 | |
| DINFVFTGFSVNGKV | 121 | Q15155 | |
| ENDDFFVRKTGVFHA | 511 | Q8WWI1 | |
| STGEAFVQFASKEIA | 56 | P31942 | |
| KGFAFVEFETKEQAA | 166 | Q4G0J3 | |
| NVFVVSVFAEAFFGK | 311 | P49281 | |
| SVFAEAFFGKTNEQV | 316 | P49281 | |
| FALENFTVSAAKFAE | 281 | Q96GN5 | |
| FEGNLALFDKAAVFE | 206 | Q96F86 | |
| TKAADFVKAFILGFQ | 131 | Q9NRX1 | |
| FDTNFFGAVRLVKAV | 111 | Q9NYR8 | |
| AFNKVAVYDTDVFAL | 51 | Q7RTS6 | |
| FADSFGFNLVSVKEF | 66 | Q16821 | |
| VSRQAFEADIAAGKF | 531 | Q8N3R9 | |
| RGVSFTFGAEVVAKF | 221 | P62136 | |
| FFLVNSVANEEGFAK | 221 | Q7Z6W7 | |
| DADSFVKFALGSVVA | 31 | Q01780 | |
| DSDQVFIGFVLKQFE | 1466 | P42858 | |
| ERETFQKFSVNGDFI | 456 | Q8N6C5 | |
| FTIENQGVTDFKFAL | 3191 | Q4G0P3 | |
| FSFITDDQVEGFAKL | 401 | O95838 | |
| FDLVKNGESIASFFQ | 166 | Q9BXJ0 | |
| DGFFNSKVALFAAVG | 231 | P98172 | |
| RFQTDAVAKFGVIFF | 116 | Q9NY37 | |
| IKIADFGFSNEFTVG | 196 | Q9P0L2 | |
| NIKIADFGFSNEFTV | 191 | P27448 | |
| DGVARAFLKAQAAFF | 306 | Q8TEH3 | |
| VTFEAVAQAFGDELK | 186 | Q8NFF5 | |
| KAGGFNDFATLAVIF | 546 | Q8IX18 | |
| FISNSGIEKAFLFDV | 251 | Q9NQL2 | |
| IAFVLAFSVGANDVA | 31 | Q8WUM9 | |
| EFNQFAEGKLSVFAE | 866 | O75923 | |
| DAFVEVKFGNTTFKT | 26 | Q86YS7 | |
| EQEGSVNFKFGVLFA | 196 | Q5VVW2 | |
| EEISGVAFIFNQKFF | 261 | O94851 | |
| IREDKGFQFFSEQVS | 616 | Q9H4L5 | |
| DESFNIGLKFEIAFE | 1661 | Q16363 | |
| FDFNVDKAVQAFVDG | 36 | Q9NUQ6 | |
| EFEFVLSQFKDFGVR | 5491 | Q8WXH0 | |
| FDAVAQIRGEAFFFK | 336 | Q9ULZ9 | |
| FTRAVQFTEEKFGQA | 16 | Q9NR46 | |
| TVNAVAGALKAFFAD | 1326 | Q13017 | |
| VNFEEFKEGFVAVLS | 61 | Q9Y2I6 | |
| GFDFFNKITNVSAVI | 201 | A4QPH2 | |
| ADVFIVFTDNETFAG | 461 | P10155 | |
| FVFGDTLVKDVFAFQ | 246 | O43868 | |
| ADEKVIFGIEFNSTF | 596 | O95025 | |
| DVRFVFKGDADVFVN | 221 | Q6UX72 | |
| VAIESQEFFAGFKLQ | 281 | Q8N2E2 | |
| GVAAFVDFVDIKSAQ | 46 | Q96T58 | |
| LVNVKFEGSEESFTF | 191 | O00329 | |
| FGKRDFENNSVFIVD | 151 | Q6UXP9 | |
| RGVSFTFGAEVVAKF | 221 | P36873 | |
| FVFGEALVKDVFAFQ | 251 | O00337 | |
| GLFTFKDVAIEFSQE | 6 | Q86XU0 | |
| NFDDTIAEGITFIKF | 331 | Q8NBS9 | |
| IKAFTDNAVAFDTGF | 161 | Q92889 | |
| VKSCFEFFGISQVDA | 2066 | O15050 | |
| LFQQFSEVKGLDAFV | 126 | Q6P3X3 | |
| AAFGNGALFVEKFIE | 226 | P11498 | |
| FLAFGDVTVDFTQKE | 11 | Q9Y3M9 | |
| FVNRFTVNSDDFGIK | 236 | B1ANS9 | |
| GLVSLKFQDFEVEFS | 1641 | Q5THJ4 | |
| IGSTEFTEEFFNKLQ | 421 | Q9UQQ1 | |
| ADKGFNFSVGDDAFV | 381 | Q9Y2G1 |